SCHEMBL2806708

SCHEMBL2806708

Nc1cccc(C#Cc2cccnc2)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.55
PSIP1 O75475 1/20 0.55
AXL P30530 1/20 0.55
MKNK1 Q9BUB5 1/20 0.55
MKNK2 Q9HBH9 1/20 0.55
CYP2A6 P11509 6/20 0.53
CYP2C9 P11712 3/20 0.53
CYP2B6 P20813 3/20 0.53
CYP2C19 P33261 3/20 0.53
CYP2D6 P10635 3/20 0.53
CYP2E1 P05181 2/20 0.53
CYP3A4 P08684 2/20 0.53
CYP1A2 P05177 2/20 0.51
CYP2C8 P10632 1/20 0.51
GRM5 P41594 5/20 0.51
CHRNB2 P17787 2/20 0.46
CHRNA4 P43681 2/20 0.46
PIK3CA P42336 1/20 0.45
MTOR P42345 1/20 0.45
PDK1 Q15118 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4878579 0.83 GRM5 (0.62) CYP3A4GRM5PIK3CAMTORPDK1
SCHEMBL3796332 0.82 CYP2A6 (0.67) CYP2A6CYP2C9CYP2B6CYP2C19CYP2D6
SCHEMBL4968126 0.82 CYP3A4 (0.58) CYP3A4PIK3CAMTORPDK1
SCHEMBL1477185 0.78 GRM5 (0.50) CYP2A6CYP2C9CYP2B6CYP2C19CYP2D6
SCHEMBL30963914 0.78 CYP2A6 (0.50) CYP2A6CYP2C9CYP2B6CYP2C19CYP2D6
SCHEMBL2806200 0.78 CYP2A6 (0.50) CYP2A6CYP2C9CYP2B6CYP2C19CYP2D6
SCHEMBL31673182 0.78 GRM5 (0.71) CYP2A6CYP2C9CYP2B6CYP2C19CYP2D6
SCHEMBL30669242 0.78 GRM5 (0.50) CYP2A6CYP2C9CYP2B6CYP2C19CYP2D6
SCHEMBL1477031 0.78 GRM5 (0.50) CYP2A6CYP2C9CYP2B6CYP2C19CYP2D6
SCHEMBL1476990 0.78 GRM5 (0.71) CYP2A6CYP2C9CYP2B6CYP2C19CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100286353-A1 ACETYLENE COMPOUND, SALT THEREOF, CONDENSATE THEREOF, AND COMPOSITION THEREOF FUJIFILM CORPORATION (JP) 2010-11-11 US disclosed
US-20100240908-A1 ACETYLENE COMPOUND FUJIFILM CORPORATION (JP) 2010-09-23 US disclosed
EP-2202220-A1 ACETYLENE COMPOUND, SALT THEREOF, CONDENSATE THEREOF, AND COMPOSITION THEREOF Fujifilm Corporation (JP) 2010-06-30 EP disclosed
EP-2202221-A1 ACETYLENE COMPOUND Fujifilm Corporation (JP) 2010-06-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240908-A1 ACETYLENE COMPOUND NAT1, KATNA1, KAT2B MEN1 579/4885PSIP1 4380/4885AXL 3519/4885
US-20100286353-A1 ACETYLENE COMPOUND, SALT THEREOF, CONDENSATE THEREOF, AND COMPOSITION THEREOF KAT8, HDAC10, SSRP1 MEN1 379/4885PSIP1 2818/4885AXL 4473/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.